PEComa exhibit expression of melanocyte markers such as HMB45 and Melan-A, as well as myogenic markers including SMA and desmin, while they do not express the endothelial marker CD34 (29). The gene discussed is DES; the disease is neoplasm with perivascular epithelioid cell differentiation.